Institutional Ownership Tarsus Pharmaceuticals, Inc. (TARS)
This table provides information about the institutional ownership of Tarsus Pharmaceuticals, Inc. (TARS). We have compiled data on the 201 institutions that hold shares in the stock, with a total of 40.5 Million shares, which have been reported (via 13F filing form) to have a value of $1.67 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,266,714
shares
|
$139 Million
0.0% of portfolio
|
Q2 2024
Added 23.15%
|
|
Rtw Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
3,236,549
shares
|
$138 Million
2.92% of portfolio
|
Q4 2024
Reduced 5.16%
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,531,896
shares
|
$108 Million
5.35% of portfolio
|
Q4 2024
Added 3.75%
|
|
Jennison Associates LLC
|
Jan 24, 2025 Q4 2024 |
2,500,132
shares
|
$106 Million
0.09% of portfolio
|
Q4 2024
Added 14.76%
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
2,254,797
shares
|
$96 Million
9.38% of portfolio
|
Q1 2024
Added 2.27%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
2,115,162
shares
|
$90 Million
0.0% of portfolio
|
Q4 2024
Added 0.85%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,969,071
shares
|
$83.8 Million
0.01% of portfolio
|
Q4 2024
Reduced 10.84%
|
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
Feb 19, 2025 Q4 2024 |
1,909,228
shares
|
$81.3 Million
0.17% of portfolio
|
Q4 2024
New holding
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
1,587,527
shares
|
$67.6 Million
5.27% of portfolio
|
Q2 2024
Reduced 11.19%
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
Feb 14, 2025 Q4 2024 |
1,279,987
shares
|
$54.5 Million
0.22% of portfolio
|
Q4 2024
Added 115.17%
|
|
Assenagon Asset Management S.A.
|
Jan 14, 2025 Q4 2024 |
1,146,812
shares
|
$48.8 Million
0.12% of portfolio
|
Q4 2024
Added 0.49%
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
932,115
shares
|
$39.7 Million
0.01% of portfolio
|
Q4 2024
Added 36.65%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
916,856
shares
|
$39 Million
0.0% of portfolio
|
Q4 2024
Added 1.94%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
838,804
shares
|
$35.7 Million
0.0% of portfolio
|
Q4 2024
Added 0.36%
|
|
Macquarie Group LTD
Australia, C3 |
Feb 14, 2025 Q4 2024 |
815,912
shares
|
$34.7 Million
0.05% of portfolio
|
Q4 2024
Added 37.16%
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
Feb 12, 2025 Q4 2024 |
691,299
shares
|
$29.4 Million
0.06% of portfolio
|
Q4 2024
Reduced 2.5%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
644,010
shares
|
$27.4 Million
0.02% of portfolio
|
Q4 2024
Added 189.42%
|
|
Ikarian Capital, LLC
Dallas, TX |
Feb 14, 2025 Q4 2024 |
607,689
shares
|
$25.9 Million
5.55% of portfolio
|
Q4 2024
Reduced 41.02%
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Feb 13, 2025 Q4 2024 |
570,056
shares
|
$24.3 Million
0.06% of portfolio
|
Q4 2024
Reduced 2.89%
|
|
Cormorant Asset Management, LP
Boston, MA |
Feb 14, 2025 Q4 2024 |
500,000
shares
|
$21.3 Million
2.19% of portfolio
|
Q2 2024
Reduced 76.63%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
460,773
shares
|
$19.6 Million
0.0% of portfolio
|
Q4 2024
Added 92.54%
|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
445,758
shares
|
$19 Million
0.07% of portfolio
|
Q3 2022
Added 10.68%
|
|
Jefferies Financial Group Inc.
New York, NY |
Feb 27, 2025 Q4 2024 |
420,758
shares
|
$17.9 Million
0.15% of portfolio
|
Q2 2024
Added 55.4%
|
|
Gilder Gagnon Howe & CO LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
404,237
shares
|
$17.2 Million
0.26% of portfolio
|
Q4 2024
Added 5636.3%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
365,544
shares
|
$15.6 Million
0.02% of portfolio
|
Q4 2024
Added 100.74%
|